Differences in health-related quality of life of prostate cancer patients based on stage of cancer

Psycho-Oncology

Volumn 13, Issue 11, 2004, Pages 800-807

  Rosenfeld, Barry ^a   Roth, Andrew J ^b   Gandhi, Sanjay ^c   Penson, David ^d  

^a FORDHAM UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BLADDER FUNCTION; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WELLBEING;

ADULT; AGED; ANXIETY; DEPRESSION; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 9244247577     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/pon.797     Document Type: Article

References (24)

1. Beahrs OH , Henson DE , Hutter RVP et al. (eds). 1992. Manual for Staging of Cancer (4th edn). American Joint Committee on Cancer, Lippincott: Philadelphia.
2. Cella DF, Bonomi AE. 1996. The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV infection (FAHI) quality of life measurement system. In Quality of Life and Pharmacoeconomics in Clinical Trials, Spilker B (ed.). Lippon-Raven: Philadelphia; 203-214.
3. Cella D, Tulsky DS, Gray G et al. 1993. The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11: 570-579.
4. Clark JA, Rieker P, Propert KJ, Talcott JA. 1998. Changes in quality of life following treatment for early prostate cancer. Urology 53: 161-168.
5. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. 1997. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy - Prostate (FACT-P) instrument. Urology 50: 920-928.
6. Fowler Jr FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. 1995. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a Medicare survey. Urology 45: 1007-1013.
7. Hopwood P, Howell A, Maguire P. 1991. Screening for psychiatric morbidity in patients with advanced breast cancer: Validation of two self-report questionnaires. Br J Cancer 64: 353-356.
8. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. 1994. Screening for anxiety and depression in cancer patients: The effects of disease and treatment. Euro J Cancer 30: 37-40.
9. Karnofsky DA, Burchenal JH. 1949. The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, MacLeod CM (ed.). Columbia University Press: New York, NY; 191-205.
10. Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC. 1994. Quality of life of patients with prostate cancer and their spouses: The value of a database in clinical care. Cancer 73: 2791-2802.
11. Lee WR, McQuellon RP, Case D, DeGuzman AF, McCullough DL. 1999. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localised prostate cancer. J Urol 162: 403-406.
12. Litwin MS, Hays RD, Fink A et al. 1995. Quality-of-life outcomes in men treated for localised prostate cancer. JAMA 273 129-135.
13. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. 1999. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Urology 54: 503-508.
14. Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. 2000. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 164: 1973-1977.
15. Moorey S, Greer S, Watson M et al. 1991. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiat 158: 255-259.
16. Ofman US. 1994. Sexual quality of life in men with prostate cancer. Cancer 75(Suppl.): 1949-1953.
17. Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. 2001. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epi 54: 350-358.
18. Penson DF, Feng Ziding, Alan Kuniyuki et al. 2003. General quality of life 2 years following treatment for prostate cancer: What influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21: 1147-1154.
19. Razavi D, Delvaux N, Farvacques C, Robaye E. 1990. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiat 156: 79-83.
20. Roth AJ, Kornblith AB, Batel-Copel L et al. 1998. Rapid screening for psychologic distress in men with prostate cancer: A pilot study. Cancer 82: 1904-1908.
21. Roth AJ, Rosenfeld B, Kornblith AB et al. 2003. The Memorial Anxiety Scale for Prostate Cancer (MAXPC): Validation of a new scale to measure anxiety in men with prostate cancer. Cancer 97 2910-2918.
22. Steinback G, Helgesen F, Adolfsson J et al. 2002. Quality of life after radical prostatectomy or watchful waiting. NEJM 347: 790-796.
23. Wei JT, Dunn RL, Sandler HM et al. 2002. Comprehensive comparison of health-related quality of life after contemporary therapies for localised prostate cancer. J Clin Oncol 20: 557-566.
24. Zigmund AS, Snaith RP. 1983. The hospital anxiety and depression scale. Acta Psychiat Scand 67: 361-370.